High BAL sRAGE is Associated with Low Serum Eosinophils and IgE in Children with Asthma

• Main Authors: Jason T. Patregnani, Bonnie A. Brooks, Elizabeth Chorvinsky, Dinesh K. Pillai
• Format: Article
• Language: English
• Published: MDPI AG 2020-08-01
• Series: Children
• Subjects: child; asthma; glycation end products; advanced; cytokines; immunoglobulin E
• Online Access: https://www.mdpi.com/2227-9067/7/9/110

Asthma remains the most common chronic lung disease in childhood in the United States. The receptor for advanced glycation end products (RAGE) has been recognized as both a marker of and participant in pulmonary pathophysiology. While membrane-bound RAGE (mRAGE) perpetuates the type 2 immune response, the soluble form (sRAGE) may act as a decoy receptor for pro-inflammatory ligands. Bronchoalveolar samples from 45 pediatric patients with asthma were obtained. Patients were divided into high and low BAL sRAGE groups using median sRAGE. Descriptive statistical analysis and non-parametric testing were applied. Children in the “high” sRAGE group had a lower median serum eosinophil (0.27 [SE ± 0.04] vs. 0.57 [± 0.06] K/mcl, adjusted <i>p</i> = 0.003) and lower serum IgE level (194.4 [± 60.7] vs. 676.2 ± 140.5) IU/mL, adjusted <i>p</i> = 0.004) as compared to the “low” sRAGE group. When controlling for age and body mass index percentile, absolute eosinophil count (<i>p</i> = 0.03) and serum IgE (<i>p</i> = 0.043) remained significantly lower in the “high” sRAGE group. Children with asthma and high levels of BAL sRAGE have lower serum eosinophil and IgE levels. These findings are consistent with the hypothesis that sRAGE may act as a decoy receptor by binding ligands that normally interact with mRAGE.